Your session is about to expire
← Back to Search
Behavioral Intervention
Arm 1: Intervention for Insomnia
Phase < 1
Waitlist Available
Led By Chelsey R Wilks, PhD
Research Sponsored by University of Missouri, St. Louis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
clinical insomnia (defined by scoring ≥ 15 on the insomnia severity index)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
The goal of this research is to establish a proof of concept for optimizing and evaluating a personalized SMS intervention based for individuals with chronic sleep problems.
Eligible Conditions
- Insomnia
- Sleep Disorders
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Insomnia Severity Index
Secondary outcome measures
System Usability Scale
Other outcome measures
Difficulties in Emotion Regulation Scale
Flinders Fatigue Scale
PROMIS: Sleep related impairment
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Arm 1: InterventionExperimental Treatment1 Intervention
Participants (N=50) who endorse insomnia will be followed for 8 weeks. All participants will be asked to download a separate app to passively monitor sleep that will inform the personalized messages. Participants will also be asked to respond to daily prompts in order to validate the passive sleep data. The study includes two phases: (1) a training and validation phase and (2) an intervention phase. During phase 1, participants' sleep habits and other behaviors will be monitored for two weeks in order to validate and optimize the SMS personalized sleep intervention (PSI). In phase 2, participants will be transitioned to the intervention phase of the study.
Find a Location
Who is running the clinical trial?
University of Missouri, St. LouisLead Sponsor
14 Previous Clinical Trials
2,609 Total Patients Enrolled
Chelsey R Wilks, PhDPrincipal InvestigatorUniversity of Missouri, St. Louis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
California
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger